Synaptogenix, Inc. (SNPX) NASDAQ

7.85

+1.805(+29.86%)

Updated at June 30 04:00PM

Currency In USD

Valuation

Market Cap4.28M
Enterprise Value-13.38M
P/E Ratio-0.75
PEG Ratio-0.05
Price/Sales Ratio1,161.39
Price/Book Ratio1.25
Enterprise/Revenue1,007.52
Enterprise/EBITDA-1.6

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-2,836.48
Operating Margin-860.45

Management Effectiveness

Return On Assets-1.45
Return On Equity-2.26

Income Statement

Revenue0
Revenue/Share0
Gross Profit-5,580
EBITDA-12.76M
Net Income-12.77M
Diluted EPS-10.99

Balance Sheet

Total Cash1.45M
Total Cash/Share0.57
Total Debt0
Total Debt/Equity0
Current Ratio17.61
Book Value Per Share6.54

Price History

52-Week Change96.74
52-Week High8.94
52-Week Low1.84
Moving Average 50 Days3.64
Moving Average 200 Days3.08

Statistics

Average Volume933,139
Shares Outstanding1.39M
% Held by Institutions93.27

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.01
Last Split Factor1:25
Last Split DateApril 05, 2024